Literature DB >> 27244487

International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007.

Jessica L Petrick1, Megan Braunlin1, Mathieu Laversanne2, Patricia C Valery3, Freddie Bray2, Katherine A McGlynn1.   

Abstract

Primary liver cancer, the most common histologic types of which are hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), is the second leading cause of cancer death worldwide. While rising incidence of liver cancer in low-risk areas and decreasing incidence in some high-risk areas has been reported, trends have not been thoroughly explored by country or by histologic type. We examined liver cancer incidence overall and by histology by calendar time and birth cohort for selected countries between 1978 and 2007. For each successive 5-year period, age-standardized incidence rates were calculated from volumes V-IX of the Cancer Incidence in Five Continents electronic database (CI5plus) and the newly released CI5X (volume X) database. Wide global variations persist in liver cancer incidence. Rates of liver cancer remain highest in Asian countries, specifically Eastern and South-Eastern Asian countries. While rates in most of these high-risk countries have been decreasing in recent years, rates in India and several low-risk countries of Africa, Europe, the Americas, and Oceania have been on the rise. Liver cancer rates by histologic type tend to convey a similar temporal profile. However, in Thailand, France, and Italy, ICC rates have increased while HCC rates have declined. We expect rates in high-risk countries to continue to decrease, as the population seroprevalence of hepatitis B virus (HBV) continues to decline. In low-risk countries, targeted screening and treatment of the hepatitis C virus (HCV), treatment of diabetes and primary prevention of obesity, will be key in reducing future liver cancer incidence.
© 2016 UICC.

Entities:  

Keywords:  incidence; international; liver cancer; trends

Mesh:

Year:  2016        PMID: 27244487      PMCID: PMC5310166          DOI: 10.1002/ijc.30211

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  29 in total

1.  Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.

Authors:  J J Ott; G A Stevens; J Groeger; S T Wiersma
Journal:  Vaccine       Date:  2012-01-24       Impact factor: 3.641

Review 2.  Screening and detection of hepatocellular carcinoma.

Authors:  Heather N Simpson; Brendan M McGuire
Journal:  Clin Liver Dis       Date:  2015-02-28       Impact factor: 6.126

3.  Graphical presentation of trends in rates.

Authors:  S S Devesa; J Donaldson; T Fears
Journal:  Am J Epidemiol       Date:  1995-02-15       Impact factor: 4.897

4.  International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973-2007.

Authors:  B Trabert; J Chen; S S Devesa; F Bray; K A McGlynn
Journal:  Andrology       Date:  2014-10-20       Impact factor: 3.842

5.  International testicular cancer incidence trends: generational transitions in 38 countries 1900-1990.

Authors:  Ariana Znaor; Joannie Lortet-Tieulent; Mathieu Laversanne; Ahmedin Jemal; Freddie Bray
Journal:  Cancer Causes Control       Date:  2014-11-12       Impact factor: 2.506

Review 6.  Cancer risk diversity in non-western migrants to Europe: An overview of the literature.

Authors:  Melina Arnold; Oliver Razum; Jan-Willem Coebergh
Journal:  Eur J Cancer       Date:  2010-09       Impact factor: 9.162

7.  Improved survival after variceal bleeding in patients with cirrhosis over the past two decades.

Authors:  Nicolas Carbonell; Arnaud Pauwels; Lawrence Serfaty; Olivier Fourdan; Victor George Lévy; Raoul Poupon
Journal:  Hepatology       Date:  2004-09       Impact factor: 17.425

8.  Sofosbuvir for previously untreated chronic hepatitis C infection.

Authors:  Eric Lawitz; Alessandra Mangia; David Wyles; Maribel Rodriguez-Torres; Tarek Hassanein; Stuart C Gordon; Michael Schultz; Mitchell N Davis; Zeid Kayali; K Rajender Reddy; Ira M Jacobson; Kris V Kowdley; Lisa Nyberg; G Mani Subramanian; Robert H Hyland; Sarah Arterburn; Deyuan Jiang; John McNally; Diana Brainard; William T Symonds; John G McHutchison; Aasim M Sheikh; Zobair Younossi; Edward J Gane
Journal:  N Engl J Med       Date:  2013-04-23       Impact factor: 91.245

9.  Global estimates of the prevalence of diabetes for 2010 and 2030.

Authors:  J E Shaw; R A Sicree; P Z Zimmet
Journal:  Diabetes Res Clin Pract       Date:  2009-11-06       Impact factor: 5.602

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  121 in total

1.  A reliable LC-MS/MS method for the quantification of natural amino acids in mouse plasma: Method validation and application to a study on amino acid dynamics during hepatocellular carcinoma progression.

Authors:  Zhenzhen Liu; Mei-Juan Tu; Chao Zhang; Joseph L Jilek; Qian-Yu Zhang; Ai-Ming Yu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2019-06-02       Impact factor: 3.205

Review 2.  The Pregnancy Pickle: Evolved Immune Compensation Due to Pregnancy Underlies Sex Differences in Human Diseases.

Authors:  Heini Natri; Angela R Garcia; Kenneth H Buetow; Benjamin C Trumble; Melissa A Wilson
Journal:  Trends Genet       Date:  2019-07       Impact factor: 11.639

3.  Hepatocellular Carcinoma: A Roadmap to Reduce Incidence and Future Burden.

Authors:  Amit G Singal; Caitlin C Murphy
Journal:  J Natl Cancer Inst       Date:  2019-06-01       Impact factor: 13.506

4.  Hepatocellular Carcinoma with Orbital Metastasis: a Unique Multidisciplinary Case Report.

Authors:  Matthew Michael Sochat; Jinhua Piao; Nishant Poddar
Journal:  J Gastrointest Cancer       Date:  2019-12

Review 5.  Disease Burden of Hepatocellular Carcinoma: A Global Perspective.

Authors:  Mehmet Sayiner; Pegah Golabi; Zobair M Younossi
Journal:  Dig Dis Sci       Date:  2019-04       Impact factor: 3.199

Review 6.  Global epidemiology and burden of HCV infection and HCV-related disease.

Authors:  Aaron P Thrift; Hashem B El-Serag; Fasiha Kanwal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-12-07       Impact factor: 46.802

Review 7.  Position 2: Transarterial Radioembolization Should Be the Primary Locoregional Therapy for Unresectable Hepatocellular Carcinoma.

Authors:  Syed Irfan-Ur Rahman; Laura Nunez-Herrero; Jamie Lee Berkes
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-03-26

8.  A systematic review of publications on charged particle therapy for hepatocellular carcinoma.

Authors:  Hiroshi Igaki; Masashi Mizumoto; Toshiyuki Okumura; Kiyoshi Hasegawa; Norihiro Kokudo; Hideyuki Sakurai
Journal:  Int J Clin Oncol       Date:  2017-09-04       Impact factor: 3.402

9.  Bacterial Translocation and Risk of Liver Cancer in a Finnish Cohort.

Authors:  Baiyu Yang; Jessica L Petrick; Jake E Thistle; Ligia A Pinto; Troy J Kemp; Hao Quang Tran; Andrew T Gewirtz; Tim Waterboer; Veronika Fedirko; Mazda Jenab; Barry I Graubard; Stephanie J Weinstein; Demetrius Albanes; Katherine A McGlynn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-02       Impact factor: 4.254

10.  Projections of primary liver cancer to 2030 in 30 countries worldwide.

Authors:  Patricia C Valery; Mathieu Laversanne; Paul J Clark; Jessica L Petrick; Katherine A McGlynn; Freddie Bray
Journal:  Hepatology       Date:  2017-12-23       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.